Activities
The Evolving Treatment Landscape for ALK-Positive Metastatic Non-Small Cell Lung Cancer: Supportive Care Considerations for Specialty Pharmacists
0290-0000-21-256-L01-P
This activity will review the optimal place in therapy for ALK inhibitors while emphasizing the role of the pharmacist in caring for this patient population.
8-19-2021
1.00
Optimizing Clinical Outcomes in Spinal Muscular Atrophy With the Use of Novel Disease-Modifying Therapies: A Review for Pharmacists
0290-0000-21-184-H01-P
This activity will incorporate a DecisionSim, allowing participants to follow cases of patients with SMA and providing an opportunity to immediately implement the knowledge gained from the article.
2.50
The Science of Opioids: Evaluating New Therapies to Optimize Opioid Stewardship
0290-0000-20-388-H01-P
This article will review essential elements of pharmacokinetics of new and emerging agents and available clinical data pharmacists can draw from to support the safe inclusion of opioids in potential health-system treatment algorithms.
2.00
A Review of Advancements in Hepatorenal Syndrome Acute Kidney Injury (HRS AKI) Treatment Approaches to Improve Patient Outcomes
0290-0000-21-119-H01-P
This activity will review current and emerging treatment approaches in HRS and the role of the health-system pharmacist in serving as a bridge between physicians and patients with HRS.
2.00